{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:49:05Z","timestamp":1767383345579,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.medcli.2023.01.023","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T07:56:50Z","timestamp":1680249410000},"page":"484-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication"],"prefix":"10.1016","volume":"160","author":[{"given":"Maria","family":"Badarinza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Serban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavinia","family":"Maghear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Andrei","family":"Pelea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana-Ioana","family":"Rosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-7970","authenticated-orcid":false,"given":"Daniela","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Stancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.01.023_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","article-title":"B cells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment","volume":"39","author":"Cornec","year":"2012","journal-title":"J Autoimmunity"},{"issue":"Suppl. 1","key":"10.1016\/j.medcli.2023.01.023_bib0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/eos.12536","article-title":"Current concepts on Sjogren's syndrome \u2013 classification criteria and biomarkers","volume":"126","author":"Jonsson","year":"2018","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.medcli.2023.01.023_bib0150","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0961203319857132","article-title":"Prognostic markers of lymphoma development in primary Sjogren syndrome","volume":"28","author":"Retamozo","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2023.01.023_bib0155","doi-asserted-by":"crossref","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2023.01.023_bib0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/bmm-2017-0297","article-title":"Biomarkers for Sj\u00f6gren's syndrome","volume":"12","author":"Baldini","year":"2018","journal-title":"Biomark Med"},{"key":"10.1016\/j.medcli.2023.01.023_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases \u2013 evidence based analysis","volume":"18","author":"Giacomelli","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2023.01.023_bib0170","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14789450.2017.1333904","article-title":"Updates on Sj\u00f6gren's syndrome: from proteomics to protein biomarkers","volume":"14","author":"Baldini","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.medcli.2023.01.023_bib0175","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00296-020-04548-x","article-title":"Shear wave elastography as a new method to identify parotid lymphoma in primary Sj\u00f6gren Syndrome patients: an observational study","volume":"40","author":"B\u0103d\u0103r\u00eenz\u0103","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.medcli.2023.01.023_bib0180","first-page":"138","article-title":"Differentiation of benign and malignant parotid gland tumors with MRI and diffusion weighted imaging","volume":"36","author":"Orhan Soylemez","year":"2021","journal-title":"Medeni Med J"},{"key":"10.1016\/j.medcli.2023.01.023_bib0185","doi-asserted-by":"crossref","first-page":"850998","DOI":"10.3389\/fimmu.2022.850998","article-title":"Role of the CXCL13\/CXCR5 axis in autoimmune diseases","volume":"13","author":"Pan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-immunol-041015-055649","article-title":"Chemokines and chemokine receptors in lymphoid tissue dynamics","volume":"34","author":"Schulz","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0195","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ijc.34299","article-title":"Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: a pooled analysis","volume":"152","author":"Rhee","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.medcli.2023.01.023_bib0200","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-16-2345","article-title":"Biomarker dynamics in b-cell lymphoma: a longitudinal prospective study of plasma samples up to 25 years before diagnosis","volume":"77","author":"Sp\u00e4th","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.medcli.2023.01.023_bib0205","doi-asserted-by":"crossref","first-page":"654543","DOI":"10.3389\/fneur.2021.654543","article-title":"CXCL13 and CXCL9 CSF levels in central nervous system lymphoma-diagnostic, therapeutic, and prognostic relevance","volume":"12","author":"Masouris","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0210","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.180.7.5130","article-title":"CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization","volume":"180","author":"Barone","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0215","doi-asserted-by":"crossref","first-page":"705079","DOI":"10.3389\/fimmu.2021.705079","article-title":"Serum, but not saliva, CXCL13 levels associate with infiltrating CXCL13+ cells in the minor salivary gland lesions and other histologic parameters in patients with Sj\u00f6gren's syndrome","volume":"12","author":"Chatzis","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/kez255","article-title":"CXCL13 as biomarker for histological involvement in Sj\u00f6gren's syndrome","volume":"59","author":"Colafrancesco","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2023.01.023_bib0225","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sj\u00f6gren's syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0230","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13075-016-1006-1","article-title":"Identification of definitive serum biomarkers associated with disease activity in primary Sj\u00f6gren's syndrome","volume":"18","author":"Nishikawa","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"Suppl. 133","key":"10.1016\/j.medcli.2023.01.023_bib0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.55563\/clinexprheumatol\/fp741f","article-title":"Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sj\u00f6gren's syndrome","volume":"39","author":"Loureiro-Amigo","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0240","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00296-020-04524-5","article-title":"Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sj\u00f6gren's syndrome","volume":"40","author":"Traianos","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.medcli.2023.01.023_bib0245","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1189\/jlb.0113036","article-title":"CXCL13 is elevated in Sj\u00f6gren's syndrome in mice and humans and is implicated in disease pathogenesis","volume":"94","author":"Kramer","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sjogren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0255","doi-asserted-by":"crossref","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sjogren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.medcli.2023.01.023_bib0260","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-3083.2002.01058.x","article-title":"Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sj\u00f6gren's syndrome","volume":"55","author":"Salomonsson","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.medcli.2023.01.023_bib0265","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/art.21062","article-title":"Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sj\u00f6gren's syndrome","volume":"52","author":"Barone","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2023.01.023_bib0270","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s10067-022-06210-2","article-title":"Elevated CXCL13 in primary Sj\u00f6gren's syndrome and its correlation with disease activity: a systematic review and meta-analysis","volume":"41","author":"Zhu","year":"2022","journal-title":"Clin Rheumatol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:56:23Z","timestamp":1758419783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775323000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0025775323000945"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.01.023","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}